Shanliang Hu
Overview
Explore the profile of Shanliang Hu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
88
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ma J, Ma X, Zhang W, Hu S, Zang R, Wu X, et al.
Technol Cancer Res Treat
. 2025 Jan;
24:15330338251317571.
PMID: 39887207
Background: Small cell lung cancer is sensitive to chemotherapy and radiotherapy, but local recurrence and distant metastasis occur shortly after treatment. This study aimed to evaluate the real-world value of...
2.
Wang C, Fang J, Jiang T, Hu S, Wang P, Liu X, et al.
EJNMMI Phys
. 2024 Mar;
11(1):24.
PMID: 38441779
Background: We combined the metabolic features of F-FDG-PET/CT and hematological inflammatory indicators to establish a predictive model of the outcomes of patients with locally advanced non-small cell lung cancer (LA-NSCLC)...
3.
Wang C, Zhao K, Hu S, Dong W, Gong Y, Xie C
Oncologist
. 2023 Apr;
28(6):e397-e405.
PMID: 37116899
Background: The purpose of this analysis was to investigate the effectiveness of afatinib compared to that of osimertinib in patients with non-small cell lung cancer (NSCLC) who harbored uncommon epidermal...
4.
Yan S, Zhu Y, Li L, Qin S, Yuan J, Chang X, et al.
Food Funct
. 2022 Dec;
14(1):427-444.
PMID: 36515227
Alginate oligosaccharide is a kind of prebiotic with broad application prospects. However, little attention is paid to the recovery effect of alginate oligosaccharide on disordered intestinal microecology caused by azithromycin....
5.
Dong W, Wang C, Wang C, Zhao K, Ma Z, Hu S
Front Oncol
. 2022 Nov;
12:999606.
PMID: 36425553
Background: Uncommon epidermal growth factor receptor (EGFR) mutations consist of a heterogeneous population of molecular alterations, and the available clinical data on the outcomes of patients with non-small-cell lung cancer...
6.
Zhang Y, Li L, Qin S, Yuan J, Xie X, Wang F, et al.
Front Nutr
. 2022 Oct;
9:996614.
PMID: 36225866
C-phycocyanin is a natural protein extracted from . We aim to investigate the preventive effect of C-phycocyanin on cisplatin chemotherapy-induced oxidative damage and inflammation. The result showed that C-phycocyanin treatment...
7.
Hu S, Wang C, Wang C, Zhao K, Wang Z, Dong W
Front Pharmacol
. 2022 Sep;
13:986962.
PMID: 36091840
In this pooled analysis, the aim was to investigate the clinicopathological characteristics of patients with uncommon epidermal growth factor receptor (EGFR) (ucm-EGFRms) along with their treatment responses and survival following...
8.
Wang C, Zhao K, Hu S, Dong W, Gong Y, Li M, et al.
Lung Cancer
. 2022 Aug;
172:86-93.
PMID: 36027855
Background: The purpose of this study was to investigate the outcomes of gefitinib and erlotinib in patients with non-small cell lung cancer (NSCLC) with uncommon epidermal growth factor receptor (EGFR)...
9.
Yuan J, Qin S, Hu S, Liu Z, Song Y, Li L
Appl Microbiol Biotechnol
. 2022 Jul;
106(13-16):5197-5209.
PMID: 35779098
Recent studies have provided compelling evidence linking the composition of the gut microbiota, host diet, and host physiology. Prebiotics are substrates that are selectively utilized by host microorganisms, conferring health...
10.
Zhang Y, Qin S, Song Y, Yuan J, Hu S, Chen M, et al.
Front Immunol
. 2022 Apr;
13:857242.
PMID: 35432359
Alginate oligosaccharide is the depolymerized product of alginate, a natural extract of brown algae, which is associated with beneficial health effects. Here, we aimed to investigate the mechanism which alginate...